Recent Updates
Recently added Catalysts
RCEL Negative Sentiment Score: 25/100

AVITA Medical, Inc. Investors: Company Investigated by the Portnoy Law Firm

Key Takeaway: AVITA Medical, Inc. is under investigation by the Portnoy Law Firm for potential securities fraud, following a significant decline in share price. The investigation comes after the company reported a backlog in unpaid claims, which negatively affected the demand for its Recell product. As a result of these issues, the company's stock fell by about 21% on August 8, 2025, prompting investment loss concerns among shareholders. The law firm is encouraging affected investors to come forward to explore legal avenues for recovering losses.

Market Sentiment Analysis

CONCERNS & RISKS

  • AVITA Medical is being investigated for possible securities fraud.
  • A significant backlog in unpaid claims has impacted the company's revenue.
  • The share price fell approximately 21% following poor financial results.

Full Press Release Details

Investors can contact the law firm at no cost to learn more about recovering their losses
​LOS ANGELES, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises AVITA Medical, Inc. (“Avita” or “the Company”) (NASDAQ : RCEL) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Avita investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: info@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
On August 7, 2025, AVITA released its second quarter 2025 financial results, disclosing that “a six-month backlog in unpaid provider claims for Recell procedures impacted first-half demand.” The Company explained that contractors assigned by the Centers for Medicare & Medicaid Services to establish pricing for its wound care product, Recell, either failed to assign an appropriate price or failed to adjudicate claims in a timely manner. As a result, claims from January through June accumulated, creating a significant backlog of unpaid and underpaid claims to providers. This uncertainty over payment expectations and timelines, according to the Company, led to reduced utilization of Recell during the first half of the year.
On this news, AVITA’s share price fell $1.13, or approximately 21%, from $5.38 on August 7, 2025, to $4.25 on August 8, 2025.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bars
Attorney Advertising

Tags

Frequently Asked Questions

What is AVITA Medical being investigated for?

AVITA Medical is under investigation for possible securities fraud.

How can AVITA investors seek compensation?

Investors can contact Lesley Portnoy for a complimentary case evaluation.

What caused AVITA's share price to drop?

AVITA's share price fell due to a backlog in unpaid provider claims.

What was the share price decline on August 8, 2025?

The share price dropped approximately 21%, from $5.38 to $4.25.

Who can AVITA investors contact for help?

Investors can reach out to attorney Lesley Portnoy via phone or email.

Last updated: Sep 9, 2025